RES
1r:r1
REP
REP1:7o(4+1)2d=-1--1
RES
2b:b-lman-HEX-1:5|6:d
3b:a-lman-HEX-1:5|6:d
4b:a-lman-HEX-1:5|6:d
5b:a-dglc-HEX-1:5
6b:a-dglc-HEX-1:5|6:a
7b:b-dglc-HEX-1:5
LIN
1:2o(3+1)3d
2:3o(3+1)4d
3:4o(2+1)5d
4:5o(6+1)6d
5:4o(3+1)7d

• Abeyta M et al. Genetic alteration of capsule type but not PspA type affects accessibility of surface-bound complement and surface antigens of Streptococcus pneumoniae. Infect Immun. 2003 Jan;71:(1):218-25. doi: 10.1128/iai.71.1.218-225.2003. PMID: 12496169.

• Cartee RT et al. CpsE from type 2 Streptococcus pneumoniae catalyzes the reversible addition of glucose-1-phosphate to a polyprenyl phosphate acceptor, initiating type 2 capsule repeat unit formation. J Bacteriol. 2005 Nov;187:(21):7425-33. doi: 10.1128/JB.187.21.7425-7433.2005. PMID: 16237026.

• Abeygunawardana C et al. Development and validation of an NMR-based identity assay for bacterial polysaccharides. Anal Biochem. 2000 Mar 15;279:(2):226-40. doi: 10.1006/abio.1999.4470. PMID: 10706792.

• Park S et al. Identification of a simple chemical structure associated with protective human antibodies against multiple pneumococcal serogroups. Infect Immun. 2009 Aug;77:(8):3374-9. doi: 10.1128/IAI.00319-09. PMID: 19451241.

• Jones C et al. NMR assays for carbohydrate-based vaccines. J Pharm Biomed Anal. 2005 Aug 10;38:(5):840-50. doi: 10.1016/j.jpba.2005.01.044. PMID: 16087046.